炎症性肠病患者非息肉样异型增生病变内镜下切除的纵向结局
这项在2个医疗中心开展的回顾性研究纳入326例炎症性肠病患者,随访1208患者年,发现36例患者共161个≥10 mm病变中63个为非息肉样病变(患病率7.7%),其中96.8%(61/63)经内镜处理,4个病变出现小范围局部复发并成功内镜再治疗,随访期间未观察到与炎症性肠病或结直肠癌相关的严重不良事件。
要点
- 非息肉样病变患病率为7.7%(36例患者中63个病变),平均大小17.8±8.9 mm。
- 96.8%(61/63)的非息肉样病变经内镜处理,4个病变出现小范围局部复发并成功内镜再治疗。
- 随访期间未观察到与炎症性肠病或结直肠癌相关的严重不良事件。
核心结论
- 在该炎症性肠病队列中,非息肉样结直肠异型增生患者内镜下切除后行监测性结肠镜检查而非结肠切除术是安全有效的。
- 完全切除内镜下可切除的非息肉样结直肠异型增生后,监测性结肠镜检查应被视为安全有效的一线策略而非结肠切除术。
研究设计与样本
- 回顾性研究,纳入2个医疗中心2007年至2018年间接受结肠镜检查的炎症性肠病患者326例。
- 识别至少1个≥10 mm的非息肉样病变,评估内镜下切除可行性、局部复发率、癌症发生率、手术需求及不良事件频率。
主要发现
- 326例患者平均接受3.6±3.0次(范围1-16)结肠镜检查,总随访1208患者年。
- 36例患者共161个≥10 mm病变,其中63个为非息肉样病变(平均大小17.8±8.9 mm,范围10-45 mm),患病率7.7%。
- 96.8%(61/63)的非息肉样病变经内镜处理。
- 4个病变(平均指数病变大小32.5±11.0 mm)出现小范围局部复发,均成功经内镜再治疗。
- 随访期间未观察到与炎症性肠病或结直肠癌相关的严重不良事件。
关键数值与推荐
- 国际共识推荐:内镜下可切除的非息肉样异型增生病变完全切除后,建议行监测性结肠镜检查而非结肠切除术。
临床怎么用
- 完全切除内镜下可切除的非息肉样结直肠异型增生后,监测性结肠镜检查应被视为安全有效的一线策略而非结肠切除术。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Patients with inflammatory bowel disease (IBD) are at risk of developing dysplasia. According to the Surveillance for Colorectal Endoscopic Neoplasia Detection and Management in Inflammatory Bowel Disease Patients: International Consensus Recommendations, "After complete removal of endoscopically resectable nonpolypoid dysplastic lesions, surveillance colonoscopy is suggested rather than colectomy." We sought to add data to the literature and hypothesized that the endoscopic resection of nonpolypoid colorectal dysplasia (NP-CRD) is safe and effective. METHODS: We conducted a retrospective study of a large cohort of patients with IBD at 2 medical centers who underwent colonoscopy between 2007 and 2018. Patients with at least 1 nonpolypoid lesion ≥10 mm were identified. We measured the feasibility of endoscopic resection, incidence of local recurrence, incidence of cancer, need for surgery, and frequency of adverse events. RESULTS: We studied 326 patients who underwent a mean ± standard deviation of 3.6 ± 3.0 (range, 1-16) colonoscopies during a total follow-up of 1208 patient-years. In 36 patients, 161 lesions ≥10 mm were identified, 63 of which were nonpolypoid (mean size, 17.8 ± 8.9 mm; range, 10-45 mm) (prevalence, 7.7%). The majority of nonpolypoid lesions (96.8% [61 of 63]) were managed endoscopically. Four lesions (mean index lesion size, 32.5 ±11.0 mm) had small local recurrences that were successfully retreated with endoscopy. There were no severe adverse events related to IBD or colorectal cancer observed in the follow-up period. CONCLUSIONS: In this IBD cohort, surveillance colonoscopy rather than colectomy was found to be safe and effective in patients with NP-CRD after undergoing endoscopic resection. After complete removal of endoscopically resectable NP-CRD, surveillance colonoscopy should be considered a safe and effective first-line strategy rather than colectomy.
引用
- Kaltenbach T, Holmes I, Nguyen-Vu T, et al. Longitudinal outcomes of the endoscopic resection of nonpolypoid dysplastic lesions in patients with inflammatory bowel disease. Gastrointest Endosc. 2023. PMID: 36649745. doi:10.1016/j.gie.2023.01.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。